- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03607305
Impact of Biliopancreatic Limb Lenght on Long-term Weight Loss After Roux-en-Y Gastric Bypass
Impact of Biliopancreatic Limb Lenght on Long-term Weight Loss After Roux-en-Y Gastric
Patients were randomly assigned into 2 groups: those patients undergoing RYGB with a BPL of 70cm and those ones undergoing RYGB with a BPL of 120 cm.
Excess BMI loss 5 years after surgery was investigated
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients were randomly assigned into 2 groups: those patients undergoing Roux-en-Y gastric bypass with a biliopancreatic limb of 70cm and those ones undergoing Roux-en-Y gastric bypass with a biliopancreatic limb of 120 cm. Alimentary limb was constant in both groups (150cm).
Excess BMI loss 5 years after surgery was investigated
Study Type
Enrollment (Actual)
Phase
- Phase 3
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI >40 Kg/m2
- BMI > 35 Kg/m2 with the presence of comorbidities associated to obesity
- Age older than 18 years
Exclusion Criteria:
- Patients undergoing other bariatric techniques than RYGB
- Patients undergoing RYGB with different BPL or AL lengths than that reported for this study
- Any other surgical procedure added to the bariatric surgery
- Impossibility to comply with pre-established clinical follow-up.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: BP limb 70cm
Patients underwent a RYGB with a biliopancreatic limb of 70cm
|
Performance of RYGB with a BP limb of 70cm
|
|
Experimental: BP limb 120cm
Patients underwent a RYGB with a biliopancreatic limb of 120cm
|
Performance of RYGB with a BP limb of 120cm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight loss
Time Frame: 5 years after surgery
|
Weight loss was evaluated
|
5 years after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jaime Ruiz-Tovar, Hospital Rey Juan Carlos
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HGUE 2012-12
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.